摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(25S)-spirost-5-en-3β-ol 3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside | 91327-42-3

中文名称
——
中文别名
——
英文名称
(25S)-spirost-5-en-3β-ol 3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside
英文别名
3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galactopyranosyl-yamogenin;(25S)-spirost-5-en-3β-yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-xylopyranosyl-(1→3)]-O-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside;3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galacopyranosylyamogenin;(25S)-3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galacopyranosyl-yamogenin;aspidistrin;(2S,3R,4S,5S,6R)-2-[(2S,3R,4S,5R,6R)-2-[(2R,3R,4R,5R,6R)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(1S,2S,4S,5'S,6R,7S,8R,9S,12S,13R,16S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-18-ene-6,2'-oxane]-16-yl]oxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
(25S)-spirost-5-en-3β-ol 3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside化学式
CAS
91327-42-3
化学式
C50H80O22
mdl
——
分子量
1033.17
InChiKey
XGYNVBAFYOIJRP-UUHWPCKHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.50±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    72
  • 可旋转键数:
    11
  • 环数:
    10.0
  • sp3杂化的碳原子比例:
    0.96
  • 拓扑面积:
    335
  • 氢给体数:
    12
  • 氢受体数:
    22

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Sugiyama, Mari; Nakano, Kimiko; Tomimatsu, Toshiaki, Chemical and pharmaceutical bulletin, 1984, vol. 32, # 4, p. 1365 - 1372
    摘要:
    DOI:
  • 作为产物:
    描述:
    (25S)-26-[(β-D-glucopyranosyl)oxy]furosta-5,20(22)-dien-3β-yl O-β-D-glucopyranosyl-(1→2)-O-[β-D-xylopyranosyl-(1→3)]-O-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside 在 β-D-glucosidase 、 作用下, 以 aq. acetate buffer 为溶剂, 反应 12.0h, 以1 mg的产率得到(25S)-spirost-5-en-3β-ol 3-O-β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside
    参考文献:
    名称:
    Steroidal Glycosides from Convallaria majalis Whole Plants and Their Cytotoxic Activity
    摘要:
    铃兰(百合科)全草的植物化学研究表明,从中提取出了15种甾体苷类化合物(1-15),其中包括9个含有lycotetrose结构单元的新化合物(4-6,10-15)。新化合物的结构通过二维核磁共振(NMR)分析和化学方法确定。所分离的化合物对HL-60人类早幼粒细胞白血病细胞、A549人类肺腺癌细胞以及HSC-4和HSC-2人类口腔鳞状细胞癌细胞系进行了细胞毒性评估。其中,(25S)-螺甾-5-烯-3β-基 O-β-d-吡喃葡糖基-(1→2)-O-[β-d-吡喃木糖基-(1→3)]-O-β-d-吡喃葡糖基-(1→4)-β-d-吡喃半乳糖苷(1)对HL-60、A549、HSC-4和HSC-2细胞显示出细胞毒性活性,IC50值范围从0.96到3.15 μM。相应的呋喃甾苷类化合物1,即(25S)-26-[(β-d-吡喃葡糖基)氧]-22α-羟基呋喃甾-5-烯-3β-基 O-β-d-吡喃葡糖基-(1→2)-O-[β-d-吡喃木糖基-(1→3)]-O-β-d-吡喃葡糖基-(1→4)-β-d-吡喃半乳糖苷(8),对贴壁细胞系A549、HSC-4和HSC-2细胞显示出细胞毒性,IC50值分别为2.97、11.04和8.25 μM。螺甾烷lycotetroside(1)以剂量依赖性方式引起A549细胞的坏死性细胞死亡。相反,呋喃甾烷lycotetroside(8)以时间依赖性方式诱导A549细胞的凋亡性细胞死亡,这一点通过形态学观察和流式细胞术分析得到了证实。
    DOI:
    10.3390/ijms18112358
点击查看最新优质反应信息

文献信息

  • Sugiyama, Mari; Nakano, Kimiko; Tomimatsu, Toshiaki, Chemical and pharmaceutical bulletin, 1984, vol. 32, # 4, p. 1365 - 1372
    作者:Sugiyama, Mari、Nakano, Kimiko、Tomimatsu, Toshiaki、Nohara, Toshihiro
    DOI:——
    日期:——
  • Steroidal Glycosides from Convallaria majalis Whole Plants and Their Cytotoxic Activity
    作者:Yukiko Matsuo、Daisuke Shinoda、Aina Nakamaru、Kuni Kamohara、Hiroshi Sakagami、Yoshihiro Mimaki
    DOI:10.3390/ijms18112358
    日期:——
    Phytochemical examination of Convallaria majalis (Liliaceae) whole plants yielded 15 steroidal glycosides (1–15), including nine new compounds (4–6, 10–15) with a lycotetrose unit. The structures of the new compounds were determined using two-dimensional Nuclear magnetic resonance (NMR) analyses and chemical methods. The isolated compounds were evaluated for cytotoxicity against HL-60 human promyelocytic leukemia cells, A549 human lung adenocarcinoma cells, and HSC-4 and HSC-2 human oral squamous cell carcinoma cell lines. Of these, (25S)-spirost-5-en-3β-yl O-β-d-glucopyranosyl-(1→2)-O-[β-d-xylopyranosyl-(1→3)]-O-β-d-glucopyranosyl-(1→4)-β-d-galactopyranoside (1) exhibited cytotoxic activity against HL-60, A549, HSC-4, and HSC-2 cells with IC50 values ranging from 0.96 to 3.15 μM. The corresponding furostanol glycoside of 1, (25S)-26-[(β-d-glucopyranosyl)oxy]-22α-hydroxyfurost-5-en-3β-yl O-β-d-glucopyranosyl-(1→2)-O-[β-d-xylopyranosyl-(1→3)]-O-β-d-glucopyranosyl-(1→4)-β-d-galactopyranoside (8), was cytotoxic to the adherent cell lines of A549, HSC-4, and HSC-2 cells with IC50 values of 2.97, 11.04, and 8.25 μM, respectively. The spirostanol lycotetroside (1) caused necrotic cell death in A549 cells in a dose-dependent manner. Alternatively, the furostanol lycotetroside (8) induced apoptotic cell death in A549 cells in a time-dependent manner, as was evident by morphological observations and flow cytometry analyses.
    铃兰(百合科)全草的植物化学研究表明,从中提取出了15种甾体苷类化合物(1-15),其中包括9个含有lycotetrose结构单元的新化合物(4-6,10-15)。新化合物的结构通过二维核磁共振(NMR)分析和化学方法确定。所分离的化合物对HL-60人类早幼粒细胞白血病细胞、A549人类肺腺癌细胞以及HSC-4和HSC-2人类口腔鳞状细胞癌细胞系进行了细胞毒性评估。其中,(25S)-螺甾-5-烯-3β-基 O-β-d-吡喃葡糖基-(1→2)-O-[β-d-吡喃木糖基-(1→3)]-O-β-d-吡喃葡糖基-(1→4)-β-d-吡喃半乳糖苷(1)对HL-60、A549、HSC-4和HSC-2细胞显示出细胞毒性活性,IC50值范围从0.96到3.15 μM。相应的呋喃甾苷类化合物1,即(25S)-26-[(β-d-吡喃葡糖基)氧]-22α-羟基呋喃甾-5-烯-3β-基 O-β-d-吡喃葡糖基-(1→2)-O-[β-d-吡喃木糖基-(1→3)]-O-β-d-吡喃葡糖基-(1→4)-β-d-吡喃半乳糖苷(8),对贴壁细胞系A549、HSC-4和HSC-2细胞显示出细胞毒性,IC50值分别为2.97、11.04和8.25 μM。螺甾烷lycotetroside(1)以剂量依赖性方式引起A549细胞的坏死性细胞死亡。相反,呋喃甾烷lycotetroside(8)以时间依赖性方式诱导A549细胞的凋亡性细胞死亡,这一点通过形态学观察和流式细胞术分析得到了证实。
查看更多